Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Diffuse Bio
Diffuse Bio

Diffuse Bio

Pre-Seed

Diffuse Bio: AI-driven platform for protein-based drug design.

HQ
San Francisco, CA, US
Founded
2022
Accelerator
Y Combinator logoY CombinatorW23
Overview
Compare
Fundraising
Employees

At Diffuse Bio we’re building a push-button entirely AI software platform for molecular design, leveraging breakthroughs in generative AI.

Our team has been behind breakthroughs in AI protein design for the past 6 years, including the first experimental validation of AI-generated proteins and diffusion models for protein structure and sequence.

Diffuse Bio - Similar Companies

Lavo Life Sciences logo

Lavo Life Sciences

Pando Bioscience logo

Pando Bioscience

pando.bio

Parallel Bio logo

Parallel Bio

parallel.bio

Menten AI logo

Menten AI

menten.ai

Nabla Bio logo

Nabla Bio

nabla.bio

Genesis Therapeutics logo

Genesis Therapeutics

Modulari-T logo

Modulari-T

modularit.bio

Medium Biosciences logo

Medium Biosciences

medium.bio

Altay Therapeutics logo

Altay Therapeutics

Forcyte Biotechnologies logo

Forcyte Biotechnologies

forcytebio.com

Persist AI logo

Persist AI

persist-ai.com

Felix Biotechnology logo

Felix Biotechnology

felixbt.com

GEn1E Lifesciences logo

GEn1E Lifesciences

gen1e.com

Abalone Bio logo

Abalone Bio

abalonebio.com

Output Biosciences logo

Output Biosciences

outputbio.com

Diffuse Bio - Quick Facts

Who are Diffuse Bio's competitors?

Companies similar to Diffuse Bio include Lavo Life Sciences, Pando Bioscience, Parallel Bio and Menten AI.

When was Diffuse Bio founded?

Diffuse Bio was founded in 2022.

Where is Diffuse Bio's headquarters located?

Diffuse Bio's headquarters is located in San Francisco, CA, US.

When was Diffuse Bio's last funding round?

Diffuse Bio's most recent funding round was for $500k (USD) in April 2023.

How much has Diffuse Bio raised to-date?

As of Apr 5, 2023, Diffuse Bio has raised a total of $500k (USD).

How many employees does Diffuse Bio have?

Diffuse Bio has 5 employees as of Feb 28, 2024.

Diffuse Bio - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Design
  • Software
Tags
  • Biotech
  • GenAI
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7371Computer Programming Services